Publications - IR Sant Pau

Search

01/06/2026 Curriculum-based training improves transurethral resection of bladder tumour performance compared to conventional training: the EuropeaN Training in uRologY (ENTRY) project

Diana, P, Di Bello, F, Mas, L, Gallioli, A, Paciotti, M, Frego, N, Mottrie, A, Palou, J, Buffi, N, Breda, A. Curriculum-based training improves transurethral resection of bladder tumour performance compared to conventional training: the EuropeaN Training in uRologY (ENTRY) project. BJU INTERNATIONAL. 2026; 137(6)DOI:10.1111/bju.70223. PMID:41821175. IF:4.400(Q1/2D).

01/06/2026 Refining BCG-failure classifications in non-muscle-invasive bladder cancer

Slusarczyk, A, Scilipoti, P, Contieri, R, Krajewski, W, Claps, F, Subiela, JD, Mertens, LS, Mori, K, Grobet-Jeandin, E, Velasco, JC, Tully, K, Soria, F, Duran, PD, Puentedura, AL, Lijnen, RAG, Longoni, M, Marcq, G, Mari, A, Laukhtina, E, Afferi, L, Albisinni, S, Gallioli, A, Del Giudice, F, Boorjian, SA, Briganti, A, Shariat, SF, Gontero, P, Radziszewski, P, Moschini, M, Pradere, B. Refining BCG-failure classifications in non-muscle-invasive bladder cancer. BJU INTERNATIONAL. 2026; 137(6)DOI:10.1111/bju.70231. PMID:41858138. IF:4.400(Q1/2D).

01/06/2026 Thrombospondin-4 is upregulated in abdominal aortic aneurysm: A vasoprotective response with potential therapeutic relevance

Blanco-Casoliva, L, Puertas-Umbert, L, Alonso, J, Almendra-Pegueros, R, Varona, S, Camacho, M, Arderiu, G, Asmarats, L, Alegret, M, Martinez-Gonzalez, J, Rodriguez, C. Thrombospondin-4 is upregulated in abdominal aortic aneurysm: A vasoprotective response with potential therapeutic relevance. BRITISH JOURNAL OF PHARMACOLOGY. 2026; 183(12)DOI:10.1111/bph.70402. PMID:41814667. IF:7.700(Q1/1D).

01/06/2026 Timing of cardiogenic shock and clinical outcomes in takotsubo syndrome: A multicenter cohort study

Sans-Roselló, J, Fernández-Peregrina, E, Kuku, KO, Torres-Ruiz, G, Sionis, A, Ribas-Closa, A, Fernández-Martínez, J, Kardenass, AE, Cahís-Vela, J, Cabrera-Fernández, MA, Martínez-Rubio, A, García-García, HM. Timing of cardiogenic shock and clinical outcomes in takotsubo syndrome: A multicenter cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY. 2026; 452DOI:10.1016/j.ijcard.2026.134270. PMID:41765143. IF:3.200(Q2/3D).

01/06/2026 Complex endovascular repair of complicated abdominal aortic aneurysm due to aortocaval fistula

Bramon, E, Soto, B, Tello, C, Guerrero, R, Dilmé, J. Complex endovascular repair of complicated abdominal aortic aneurysm due to aortocaval fistula. JOURNAL OF VASCULAR SURGERY CASES INNOVATIONS AND TECHNIQUES. 2026; 12(3)DOI:10.1016/j.jvscit.2026.102161. PMID:41809018. IF:(Q/D).

01/06/2026 A multi-center retrospective study comparing one-step nucleic amplification and conventional ultrastaging for sentinel lymph node assessment in early-stage endometrial cancer

Vallés, E, Bebia, V, García-Pineda, V, Gracia, M, Hardisson, D, Díaz-Feijoo, B, Carreras, N, Fernández-González, S, Padilla-Iserte, P, Carballas, E, de la Manzanara, CL, Oliver-Pérez, R, Sanchis, J, Pantoja, M, Mancebo, G, Agababyan, C, Escayola, C, Torrent, A, del Valle, MG, Fidalgo, S, Gómez, T, Roldán, F, Alonso, P, Quesada, A, Chacón, E, Muruzabal, JC, García-Cano, DG, Calvo, A, Gil-Moreno, A, Cabrera, S. A multi-center retrospective study comparing one-step nucleic amplification and conventional ultrastaging for sentinel lymph node assessment in early-stage endometrial cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2026; 36(3)DOI:10.1016/j.ijgc.2026.104678. PMID:42066415. IF:4.700(Q1/1D).

01/06/2026 Partnership Status and Contraceptive Method Distributions in Vasectomy Patients with and Without Children: A Single-Center Analysis

Raffo, M, Curbelo, JRS, Ponce, MD, Caballero, LM, Soldi, JAA, Garcia, RC, Castro, SD, Loma, GD, Montorsi, F, Salonia, A, Ruiz-Castane, E, Luft, DV. Partnership Status and Contraceptive Method Distributions in Vasectomy Patients with and Without Children: A Single-Center Analysis. Journal of Sexual Medicine. 2026; 23DOI:10.1093/jsxmed/qdag118.472. PMID:. IF:3.300(Q1/3D).

01/06/2026 Spermatic Cord Block as a Treatment Modality in Chronic Scrotal Pain: A Tertiary Referral Center Study

Raffo, M, Luft, DV, Izquierdo, P, Curbelo, JRS, De Rocco, M, Caballero, LM, Soldi, JAA, Garcia, RC, Dumas, S, Adalid, G, Montorsi, F, Salonia, A, Ruiz-Castane, E. Spermatic Cord Block as a Treatment Modality in Chronic Scrotal Pain: A Tertiary Referral Center Study. Journal of Sexual Medicine. 2026; 23DOI:10.1093/jsxmed/qdag118.098. PMID:. IF:3.300(Q1/3D).

01/06/2026 Corporoplasty for Peyronie's Disease and Congenital Penile Curvature: Real World Effectiveness, Safety, and Patient Reported Outcomes at a Single Tertiary-Referral Center

Raffo, M, Birolini, G, Ponce, MD, Caballero, LM, Luft, DV, Soldi, JAA, Garcia, RC, Castro, SD, Montorsi, F, Ruiz-Castane, E, Salonia, A, Curbelo, JRS. Corporoplasty for Peyronie's Disease and Congenital Penile Curvature: Real World Effectiveness, Safety, and Patient Reported Outcomes at a Single Tertiary-Referral Center. Journal of Sexual Medicine. 2026; 23DOI:10.1093/jsxmed/qdag118.460. PMID:. IF:3.300(Q1/3D).

01/06/2026 Comparison of Demographic and Contraceptive Patterns in Men Undergoing Vasectomy Before and After the COVID-19 Pandemic in Barcelona, Spain

Raffo, M, Curbelo, JRS, Ponce, MD, Caballero, LM, Soldi, JAA, Garcia, RC, Dumas, S, Adalid, G, Montorsi, F, Salonia, A, Ruiz-Castane, E, Luft, DV. Comparison of Demographic and Contraceptive Patterns in Men Undergoing Vasectomy Before and After the COVID-19 Pandemic in Barcelona, Spain. Journal of Sexual Medicine. 2026; 23DOI:10.1093/jsxmed/qdag118.381. PMID:. IF:3.300(Q1/3D).

01/06/2026 Assessing Vasectomy Outcomes and Follow-up Patterns in Relation to Contraceptive Use: A Retrospective Analysis

Raffo, M, Curbelo, JRS, Ponce, MD, Caballero, LM, Soldi, JAA, Garcia, RC, Dumas, S, Adalod, G, Montorsi, F, Salonia, A, Ruiz-Castane, E, Luft, DV. Assessing Vasectomy Outcomes and Follow-up Patterns in Relation to Contraceptive Use: A Retrospective Analysis. Journal of Sexual Medicine. 2026; 23DOI:10.1093/jsxmed/qdag118.380. PMID:. IF:3.300(Q1/3D).

01/06/2026 Permanent Contraception Without Regret: Outcomes of Vasectomy in Childless Men from a Tertiary Referral Center

Raffo, M, Curbelo, JRS, Ponce, MD, Caballero, LM, Soldi, JAA, Garcia, RC, Castro, SD, Loma, GA, Montorsi, F, Salonia, A, Ruiz-Castane, E, Luft, DV. Permanent Contraception Without Regret: Outcomes of Vasectomy in Childless Men from a Tertiary Referral Center. Journal of Sexual Medicine. 2026; 23DOI:10.1093/jsxmed/qdag118.466. PMID:. IF:3.300(Q1/3D).

01/06/2026 Sperm Quality Parameters and Clinical Characteristics of Transgender Females Before Undergoing Gender-Affirming Hormonal Therapy

Ponce, MD, Troka, E, Raffo, M, Caballero, LMM, Ferlin, A, Castañe, ER, Scala, A, Garolla, A. Sperm Quality Parameters and Clinical Characteristics of Transgender Females Before Undergoing Gender-Affirming Hormonal Therapy. Journal of Sexual Medicine. 2026; 23DOI:10.1093/jsxmed/qdag118.115. PMID:. IF:3.300(Q1/3D).

01/06/2026 Post-Vasectomy Pain Syndrome and Vasectomy Complications: Real-Life Data from a Single Tertiary Referral Center

Ponce, MD, Raffo, M, Luft, DV, Montorsi, F, Salonia, A, Castañé, ER. Post-Vasectomy Pain Syndrome and Vasectomy Complications: Real-Life Data from a Single Tertiary Referral Center. Journal of Sexual Medicine. 2026; 23DOI:10.1093/jsxmed/qdag118.360. PMID:. IF:3.300(Q1/3D).

01/06/2026 One-year multicenter prospective real-world study of vericiguat effectiveness and safety in Spain

Esteban-Fernández, A, Calvo-Bernal, B, López-Vilella, R, de Lara, G, Belarte-Tornero, LC, Barrantes-Castillo, M, Gómez-Otero, I, Nuñez-Villota, J, Robles-Gamboa, C, López-Aguilera, J, Torremocha-López, A, Melendo-Viu, M, Simón-Ramón, C, Fluvià-Burgués, P, Pastor-Pérez, FJ, Alonso-Salinas, G, García-Pinilla, JM, Pomares-Varó, A, Gayán-Ordás, J, González-Calle, D, Díez-Villanueva, P, Galván-Ruiz, M, Ortiz-Cortés, C, Caravaca-Pérez, P, Goena-Vives, C, Seller, J, Jiménez-Blanco, M, Codina, P, Vietiez, JM, Jordán-Martínez, L, López-Lluva, MT, Mena-Sebastià, E, Pájaro, P, Recio-Mayoral, A. One-year multicenter prospective real-world study of vericiguat effectiveness and safety in Spain. ESC Heart Failure. 2026; 13(3)DOI:10.1093/eschf/xvag138. PMID:42128540. IF:3.700(Q1/3D).

01/06/2026 Clinicopathological correlates of FTLD-TDP type E: A deep phenotyping on an autopsy confirmed case

Aldecoa, I, Rubio-Guerra, S, García-Castro, J, Selma-González, J, Sala, I, Sánchez-Saudinós, B, Zhu, N, Barroeta, I, Rojas-Garcia, R, Turon-Sans, J, Carbayo, A, Camacho, V, Almenta, D, Pérez-Blanco, J, Bernal, S, González-Quereda, L, Caballero, G, Molina-Porcel, L, Dols-Icardo, O, Alcolea, D, Fortea, J, Lleó, A, Illán-Gala, I. Clinicopathological correlates of FTLD-TDP type E: A deep phenotyping on an autopsy confirmed case. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2026; 85(6)DOI:. PMID:. IF:3.000(Q2/4D).

01/06/2026 Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: 1-year results from the ADALA trial

Flores-Umanzor, E, Cruz-González, I, Cepas-Guillén, P, Millán, X, Antúnez-Muiños, P, Asmarats, L, Laffond, A, Regueiro, A, López-Tejero, S, Li, CHP, Sanchis, L, Rodés-Cabau, J, Arzamendi, D, Freixa, X. Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: 1-year results from the ADALA trial. REVISTA ESPANOLA DE CARDIOLOGIA. 2026; 79(6)DOI:10.1016/j.rec.2025.12.008. PMID:41412468. IF:4.900(Q1/2D).

01/06/2026 Prognostic value of early haemodynamic valve deterioration after TAVI

Trimaille, A, Morel, O, Alperi, A, Veiga-Fernandez, G, Nombela-Franco, L, Vilalta, V, Muñoz-García, A, Nuche, J, Franzone, A, Urena, M, Asmarats, L, Regueiro, A, del Trigo, M, Auffret, V, del Val, D, Serra, V, Carmona, A, Avanzas, P, Fradejas-Sastre, V, Sanchez, I, Trichilo, M, Maneiro, N, Molaro, MI, Fischer, Q, Arzamendi, D, Flores-Umanzor, E, Oteo, JF, Nolf, M, Alfonso, F, Pockels, PD, Elkadiri, C, Cepas-Guillén, P, Avvedimento, M, Rodés-Cabau, J. Prognostic value of early haemodynamic valve deterioration after TAVI. EuroIntervention. 2026; 22(11)DOI:10.4244/EIJ-D-25-01370. PMID:42186872. IF:9.500(Q1/1D).

01/06/2026 The paradox of SMURF-less outcomes and its implication for diabetes

Cenko, E, Manfrini, O, Yoon, J, Bergami, M, Vasiljevic, Z, Mendieta, G, Zdravkovic, M, Vavlukis, M, Kedev, S, Milicic, D, Ottani, F, Badimon, L, Bugiardini, R. The paradox of SMURF-less outcomes and its implication for diabetes. European Heart Journal-Quality of Care and Clinical Outcomes. 2026; 12(4)DOI:10.1093/ehjqcco/qcag012. PMID:41606783. IF:4.600(Q1/2D).

01/06/2026 Parameter-efficient adaptation of foundational models for automated myocardial strain analysis

Bernardo, A, Mato, G, Calandrelli, M, Medus, J, Curiale, A. Parameter-efficient adaptation of foundational models for automated myocardial strain analysis. Biomedical Physics & Engineering Express. 2026; 12(3)DOI:10.1088/2057-1976/ae7c09. PMID:42276109. IF:(Q/D).

01/06/2026 A multicenter prospective evaluation of the benefits of Dexcom ONE plus in subjects with type 2 diabetes on insulin therapy beyond glycemic control: results from the LIFE-ONE study

Chico, A, Aguilera-Hurtado, E, Albareda, M, Moreno-Fernández, J, Beato-Vibora, P, Fernández-Rubio, E, Cuesta, M, Bartual, A, Ampudia-Blasco, FJ, Bandrés, O, Ares, J, Rivero, MT, Picón-César, MJ. A multicenter prospective evaluation of the benefits of Dexcom ONE plus in subjects with type 2 diabetes on insulin therapy beyond glycemic control: results from the LIFE-ONE study. ACTA DIABETOLOGICA. 2026; 63(6)DOI:10.1007/s00592-026-02682-9. PMID:41964691. IF:2.900(Q3/6D).

01/06/2026 Assessing Europe's policy readiness to confront the MASLD/MASH public health threat

Lazarus, JV, White, TM, Agirre-Garrido, L, Abeysekera, KWM, Brennan, PN, Bruha, R, Buttigieg, S, Carrieri, P, Cortez-Pinto, H, Flisiak, R, Francque, SMA, Frühbeck, G, Gheorghe, LS, Hagström, H, Holleboom, AG, Ivanov, K, Jensterle, M, Jepsen, P, Kupcinskas, J, Mark, HE, Mauricio, D, Bibi, SM, Moreno, C, Mrzljak, A, Papanicolaou, E, Papp, M, Papatheodoridis, G, Peck-Radosavljevic, M, Pugliese, N, Ryan, JD, Ribeiro, RT, Salupere, R, Skladany, L, Tolmane, I, Yki-Järvinen, H, Schattenberg, JM, Pericàs, JM. Assessing Europe's policy readiness to confront the MASLD/MASH public health threat. Lancet Regional Health-Europe. 2026; 65DOI:10.1016/j.lanepe.2026.101713. PMID:42266904. IF:13.000(Q1/1D).

01/06/2026 Prevalence and clinical characteristics of erectile dysfunction among men with type 2 diabetes in primary care: A cross-sectional study in Catalonia

Martinez-Mores, S, Fillat, MBV, Vlacho, B, Navas, E, Fernandez-Camins, B, Franch-Nadal, J, Mauricio, D. Prevalence and clinical characteristics of erectile dysfunction among men with type 2 diabetes in primary care: A cross-sectional study in Catalonia. Primary Care Diabetes. 2026; 20(3)DOI:10.1016/j.pcd.2026.04.006. PMID:42000296. IF:2.300(Q2/5D).

01/06/2026 Clinical trends in Catalonia's Primary Care Setting (2018-2023) in Elderly (=75 years) and Frail Adults with Type 2 Diabetes

Ramon-Granés, M, Fernàndez-Camins, B, Lapena-Estella, C, Orfila-Pernas, F, de la Puente, JB, Vlacho, B, Mauricio, D, Navas-Méndez, E, Franch-Nadal, J. Clinical trends in Catalonia's Primary Care Setting (2018-2023) in Elderly (=75 years) and Frail Adults with Type 2 Diabetes. Primary Care Diabetes. 2026; 20(3)DOI:10.1016/j.pcd.2026.03.010. PMID:41916804. IF:2.300(Q2/5D).

01/06/2026 Glucocorticoid-Induced Positive Feedback in Cushing Disease: Insights From a Spanish Multicenter Cohort

Biagetti, B, Cardona-Arias, A, Soto-Moreno, A, García, MDO, Rodríguez, MDM, Gonzalez-Fernandez, L, Castro, A, Guerrero-Pérez, F, Iglesias, P, Camara, R, Paja, M, Lázaro, VA, Simo-Servat, A, Lozano-Aida, C, Echarri, AI, Valero, LM, Villar-Taibo, R, Bernabéu, I, Fajardo-Montañana, C, Aulinas, A, García-Centeno, R, Hanzu, F, Araujo-Castro, M. Glucocorticoid-Induced Positive Feedback in Cushing Disease: Insights From a Spanish Multicenter Cohort. Endocrine Practice. 2026; 32(6)DOI:10.1016/j.eprac.2025.12.013. PMID:41443540. IF:4.600(Q1/3D).

01/06/2026 Endovascular Interventions Reduce Rebleeding in Patients With Gastric Varices: An Individual Patient Data Meta-Analysis

Biswas, S, Aggarwal, A, Lo, GH, Luo, XF, Yang, L, Escorsell, A, Mehta, S, Swaroop, S, Agarwal, S, Agarwal, A, Saxena, S, Mishra, AK, Tripathi, S, Gunjan, D, Gamanagatti, S, Shalimar. Endovascular Interventions Reduce Rebleeding in Patients With Gastric Varices: An Individual Patient Data Meta-Analysis. Clinical Gastroenterology and Hepatology. 2026; 24(6)DOI:10.1016/j.cgh.2026.01.002. PMID:41539349. IF:12.000(Q1/1D).

01/06/2026 Prevalence and characteristics of subclinical polymyalgia rheumatica in patients with giant cell arteritis

Narváez, J, Sirvent, E, Sánchez-Rodríguez, I, Sabaté-Llobera, A, Cortés-Romera, M, Moya-Alvarado, P, Rozadilla, A, Reina, D. Prevalence and characteristics of subclinical polymyalgia rheumatica in patients with giant cell arteritis. RHEUMATOLOGY. 2026; 65(6)DOI:10.1093/rheumatology/keag285. PMID:42226006. IF:4.400(Q1/1D).

01/06/2026 Position statement on the pathological assessment of pancreatic resection specimens in pancreatic ductal adenocarcinoma by the Societat Catalana de Pàncrees and the Societat Catalana d'Anatomia Patologica

Salcedo-Allende, MT, Chimisana, VF, Llanos, ACZ, Piñol, TS, Freixas, MC, Sanz, IA, Ortiz, MR, Munoz, CM, Olivar, AA, Martos, RL, Gallego, AH, Hijos, MG, Fernández, MLD, Coma, MI, Muñoz, CG, Leal, CJB, Fumagalli, C, Szafranska, J, Borrego, MV, Cabús, SS, Piñas, JCF, Raya, ECV. Position statement on the pathological assessment of pancreatic resection specimens in pancreatic ductal adenocarcinoma by the Societat Catalana de Pàncrees and the Societat Catalana d'Anatomia Patologica. Gastroenterologia y Hepatologia. 2026; 49(6)DOI:10.1016/j.gastrohep.2026.502700. PMID:41655901. IF:1.900(Q3/7D).

01/06/2026 Who really benefits from chemotherapy in high-risk localized soft tissue sarcoma? A virtual twin analysis of ISG-STS 1001

Dossa, F, Callegaro, D, Palmerini, E, Quagliuolo, V, Martin-Broto, J, Grignani, G, Brunello, A, Blay, JY, Beveridge, RD, Ferraresi, V, Lugowska, IA, Pizzamiglio, S, Verderio, P, Palassini, E, Bianchi, G, Stacchiotti, S, Bague, S, Coindre, JM, Dei Tos, AP, Gronchi, A. Who really benefits from chemotherapy in high-risk localized soft tissue sarcoma? A virtual twin analysis of ISG-STS 1001. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(16_SUPPL)DOI:10.1200/JCO.2026.44.16_suppl.11573. PMID:. IF:41.900(Q1/1D).

01/06/2026 Whole-Body Pattern of Muscle Degeneration and Progression in Sarcoglycanopathies

Costa-Comellas, L, Monforte, M, Sanchez-Montañez, A, Romero-Duque, P, Pegoraro, E, Díaz-Manera, J, Vlodavets, D, Maggi, L, Moscatelli, M, DAmico, A, Olivé, M, Alonso-Pérez, J, Comi, G, Escudero-Fernández, JM, Urcuyo, GS, Pichiecchio, A, Berardinelli, A, Claeys, KG, Bruno, C, Panicucci, C, Bortolani, S, Torchia, E, Ricci, E, Monges, S, Bevilacqua, JA, Diaz-Jara, J, Walter, MC, Thiele, S, Lokken, N, Vissing, J, Quijano-Roy, S, Carlier, RY, Voermans, NC, Marini-Bettolo, C, Guglieri, M, Straub, V, Leonardis, L, Munell, F, Gómez-Andrés, D, Tasca, G. Whole-Body Pattern of Muscle Degeneration and Progression in Sarcoglycanopathies. Annals of Clinical and Translational Neurology. 2026; 13(6)DOI:10.1002/acn3.70303. PMID:41475892. IF:3.900(Q1/3D).

01/06/2026 Patient-specific functional networks track early cognitive alterations and minor hallucinations in Parkinson's disease

Stampacchia, S, Bernasconi, F, Van De Ville, D, Amico, E, Kohoutová, L, Taylor, JP, Thomas, A, Pagonabarraga, J, Kulisevsky, J, Blanke, O. Patient-specific functional networks track early cognitive alterations and minor hallucinations in Parkinson's disease. Nature Mental Health. 2026; 4(6)DOI:10.1038/s44220-026-00657-x. PMID:. IF:(Q/D).

01/06/2026 Simple against advanced imaging for the selection of stroke therapy in the extended window (VESTA study)

Valls-Carbó, A, Millán, M, Castaño, C, De La Ossa, NP, Cardona, P, Flores, A, Biarnes, C, Boix, M, Urra, X, Terceño, M, Olivé-Gadea, M, Renom, PC, Rodríguez-Campello, A, Purroy, FF, Yugueros, B, Cánovas, D, Caamaño, IR, Beltrán-Mármol, B, Remollo, S, De Dios, M, Bashir, S, Aja, L, Gramegna, LL, Pastrana, M, Hernández-Pérez, M. Simple against advanced imaging for the selection of stroke therapy in the extended window (VESTA study). European Stroke Journal. 2026; 11(6)DOI:10.1093/esj/aakag068. PMID:42308555. IF:4.500(Q1/2D).

01/06/2026 GH001 vs Placebo in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial

Cubala, WJ, Bajbouj, M, Bauer, M, Baune, BT, Cardoner, N, Devlin, F, Doolin, K, Herrero, RMD, Elices, M, Feeney, A, Galuszko-Wegielnik, M, Jakuszkowiak-Wojten, K, Janu, L, Kelly, JR, Ledden, K, Maclsaac, R, Madero, S, Mcinerney, SJ, Montejo, AL, Nawka, A, Pálenícek, T, Solà, VP, Ramaekers, JG, Reif, A, Ritter, P, Ryan, F, Svendsen, CB, Sweeney, C, Terwey, TH, Trivedi, MH, Valcheva, V, Vieta, E, Thase, ME. GH001 vs Placebo in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial. JAMA Psychiatry. 2026; 83(6)DOI:10.1001/jamapsychiatry.2026.0096. PMID:41879760. IF:17.100(Q1/1D).

01/06/2026 Comparison of three strategies of GvHD prophylaxis after T-cell replete haploidentical hematopoietic transplantation: Tacrolimus vs calcineurin inhibitors-MMF vs sirolimus-MMF (vol 30, pg 1025, 2024)

Esquirol, A, Pascual, MJ, Montoro, J, Piñana, JL, Ferrà, C, Herruzo, B, Garcia-Cadenas, I, Balaguer, A, Perez, A, Huguet, M, Redondo, S, Villalba, M, Hernandez-Boluda, JC, Chorao, P, Hernani, R, Sanz, J, Solano, C, Sierra, J, Martino, R. Comparison of three strategies of GvHD prophylaxis after T-cell replete haploidentical hematopoietic transplantation: Tacrolimus vs calcineurin inhibitors-MMF vs sirolimus-MMF (vol 30, pg 1025, 2024). Transplantation And Cellular Therapy. 2026; 32(6)DOI:10.1016/j.jtct.2025.06.011. PMID:40516920. IF:4.400(Q1/1D).

01/06/2026 Haploidentical Donor versus Mismatched Unrelated Donor in Reduced-Intensity Conditioning Stem Cell Transplantation: A GETH-TC

Fox, ML, Martínez, AP, Esquirol, A, Navarro, V, Cabirta, A, García-Cadenas, I, Almorox, RB, Fonseca-Santos, M, Fernando, IH, Bento, L, Raya, MP, Montoro, J, Calbacho, M, Ripa, TZ, Coll, CFI, Morales, RH, Ortí, G, Martino, R, González, PFC, López-Corral, L, Pérez-López, E, Navarro-Fernandez, J, Cascón, MJP, Sola, M, Catarineu, AT, Salamero, O, González, AP, Solano, C, Kwon, M, Valcárcel, D. Haploidentical Donor versus Mismatched Unrelated Donor in Reduced-Intensity Conditioning Stem Cell Transplantation: A GETH-TC. Transplantation And Cellular Therapy. 2026; 32(6)DOI:10.1016/j.jtct.2026.01.013. PMID:41534839. IF:4.400(Q1/1D).

01/06/2026 Combining three different pre-transplant scores improves predictive value in patients after haploidentical stem cell transplantation with TBF conditioning and PTCy (vol 27 , pg 614.e1 , 2021 )

Esquirol, A, Pascual, MJ, Garcia-Cadenas, I, Herruzo, B, Ferra, C, Torio, A, Torrent, A, Cuesta, M, Martino, R, Sierra, J. Combining three different pre-transplant scores improves predictive value in patients after haploidentical stem cell transplantation with TBF conditioning and PTCy (vol 27 , pg 614.e1 , 2021 ). Transplantation And Cellular Therapy. 2026; 32(6)DOI:10.1016/j.jtct.2025.06.010. PMID:40623446. IF:4.400(Q1/1D).

01/06/2026 Enfortumab vedotin plus pembrolizumab (EV plus P) vs chemotherapy for previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC): 3.5-year follow-up and response analyses from the phase 3 EV-302 study.

Powles, T, van der Heijden, MS, Bedke, J, Valderrama, BP, Kikuchi, E, Galsky, MD, Loriot, Y, Iyer, G, Yu, EY, Hoffman-Censits, J, Mar, N, Vulsteke, C, Sridhar, SS, Maroto-Rey, JP, Park, SH, Moreno, BH, Lichfield, J, Yu, XS, Wirtz, H, Gupta, S. Enfortumab vedotin plus pembrolizumab (EV plus P) vs chemotherapy for previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC): 3.5-year follow-up and response analyses from the phase 3 EV-302 study.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(16_SUPPL)DOI:10.1200/JCO.2026.44.16_suppl.4507. PMID:. IF:41.900(Q1/1D).

01/06/2026 Prognostic factors and impact of concomitant medication in extensive-stage small cell lung cancer (ES-SCLC) treated with first-line chemotherapy plus anti-PD-L1: A Spanish multicenter real-world study.

Portu, M, Sanz-Beltran, J, Pellicer, A, Navarro, B, Monleon, AR, Capdevila, P, Tallafigo, FL, Moran, T, Catot, S, Munoz, SP, Arriola, E, Sanchez, A, Osorio, K, Muñoz, A, Isla, D, Guarner, B, Piedra, A, Recio, SM, Barba, A, Majem, M. Prognostic factors and impact of concomitant medication in extensive-stage small cell lung cancer (ES-SCLC) treated with first-line chemotherapy plus anti-PD-L1: A Spanish multicenter real-world study.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(16_SUPPL)DOI:10.1200/JCO.2026.44.16_suppl.8107. PMID:. IF:41.900(Q1/1D).

01/06/2026 Impact of eftilagimod alfa, an APC activator via MHC class II, on lymphocyte activation and survival outcomes in metastatic cancer patients.

Forster, MD, Forget, F, Murillo, SM, García-Fructuoso, I, Ibrahim, NK, Marathe, O, Kristensen, CA, Laban, S, Metcalf, R, Majem, M, Peguero, JA, Wildiers, H, Marmé, F, Brana, I, Mueller, C, Brignone, C, Triebel, F. Impact of eftilagimod alfa, an APC activator via MHC class II, on lymphocyte activation and survival outcomes in metastatic cancer patients.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(16_SUPPL)DOI:10.1200/JCO.2026.44.16_suppl.2569. PMID:. IF:41.900(Q1/1D).

01/06/2026 Clinical impact and molecular profiling of PTEN loss and TMPRSS2:ERG fusion in metastatic hormone-sensitive prostate cancer.

Crous, C, de Herreros, MG, Torras, OR, Jimenez, N, Ferrer-Mileo, L, Garcia-Esteve, S, Rodriguez, L, Altamirano, M, Salinas, B, Cobo-Lopez, S, Fernandez-Mañas, L, Duran, MAC, Pous, AF, Chirivella, I, Figols, M, Costa, SC, Rodriguez-Vida, A, Anguera, G, González, NS, Mellado, B. Clinical impact and molecular profiling of PTEN loss and TMPRSS2:ERG fusion in metastatic hormone-sensitive prostate cancer.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(16_SUPPL)DOI:10.1200/JCO.2026.44.16_suppl.5101. PMID:. IF:41.900(Q1/1D).